Skip to content
Middletown Life
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
Alligator Bioscience
Alligator Bioscience Publishes Annual Report for 2025
March 26, 2026
New data from Investigator‑Initiated Study Evaluating Alligator Bioscience’s Mitazalimab to be Presented at AACR Annual Meeting 2026
March 18, 2026
Alligator Bioscience Strengthens Intellectual Property Protection for Bispecific Antibody Platform
March 10, 2026
Alligator Bioscience Comments on Henlius Dosing First Patient in Phase 2/3 Breast Cancer Study of HLX22
March 2, 2026
Exercise Price Determined for the Exercise of Warrants Series TO 14 in Alligator Bioscience AB
February 27, 2026
Alligator Bioscience AB Reports Full Year Financial Results for 2025 and for Q4 2025 and Provides a Business Update
February 13, 2026
Invitation to Alligator Bioscience’s Earnings Call on 12 February 2026
February 12, 2026
Change in Number of Shares and Votes in Alligator Bioscience AB
February 7, 2026
Alligator Bioscience to Present New OPTIMIZE-1 Data on Mitazalimab at ASCO Gastrointestinal Cancers Symposium 2026
January 9, 2026
Alligator Bioscience Announces Preliminary Outcome in Rights Issue
December 21, 2025
←
Previous Page
1
2